[GRADE A1 — NYDFS Consent Order (regulatory enforcement action)]
The consent order attributes the following actions to AML OFFICER-1:
January 2015: During onboarding for Epstein's Global Markets account, the consent order states AML-1 "identified recent developments in the press" including:
Escalated to AML OFFICER-2 — the correct action under compliance protocol
Pushed back when AML-2 cited the Approval Email as sufficient. The consent order quotes AML-1's reasoning:
WHAT THIS SHOWS AND DOES NOT SHOW: The consent order documents AML-1 as the compliance officer who identified emerging risks, escalated appropriately, and correctly analyzed the Approval Email's limitations. AML-1's characterization of the Approval Email as "a statement by a front office MD about his conversation" — not a direct compliance approval — is one of the most precise analytical observations in the consent order. The consent order does not attribute any compliance failure to AML-1. Their escalation triggered the ARRC review; that the ARRC's conditions were subsequently misapplied by AML-2 is documented as a separate failure.